This hottest twist during the Lykos Therapeutics saga threatens A serious overhaul of the corporate’s tactic and direction, with Musk ally and billionaire Trader Antonio Gracias appearing to desire to get the business again towards its nonprofit drug growth roots and a far more Doblinite philosophy.Disclaimer: copyright Spotlight and its guardian